| Income Statement | 2025-09-30 | |||
|---|---|---|---|---|
| Revenue | 49,298 | |||
| Cost of revenue | 37,684 | |||
| Software development | 453 | |||
| General and administrative | 16,301 | |||
| Selling and marketing | 482 | |||
| Total operating expenses | 54,920 | |||
| Operating loss from continuing operations | -5,622 | |||
| Interest income | 1,127 | |||
| Change in fair value of warrant liabilities | -33 | |||
| Realized loss from sales of short-term investments | -5,195 | |||
| Total other non-operating income (loss) | -4,035 | |||
| Net income (loss) from discontinued operations | 67,073 | |||
| Net income (loss) | 57,416 | |||
| Basic (in shares) | 82,454,657 | |||
| Diluted (in shares) | 82,454,657 | |||
| Total basic earnings (loss) per share of common stock (in dollars per share) | 0.7 | |||
| Total diluted earnings (loss) per share of common stock (in dollars per share) | 0.7 | |||
Strata Critical Medical, Inc. (SRTA)
Strata Critical Medical, Inc. (SRTA)